Sotera Health Company
SHC
$17.35
-$0.13-0.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.05% | 6.42% | 2.56% | -6.46% | 8.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.05% | 6.42% | 2.56% | -6.46% | 8.47% |
| Cost of Revenue | 4.95% | 3.16% | -1.63% | -3.32% | 8.75% |
| Gross Profit | 12.36% | 9.05% | 6.54% | -8.73% | 8.25% |
| SG&A Expenses | -3.65% | 3.61% | -2.59% | 5.14% | 18.00% |
| Depreciation & Amortization | -80.07% | -39.69% | -2.57% | -2.03% | -1.69% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.11% | -0.18% | -1.97% | -1.13% | 10.14% |
| Operating Income | 37.63% | 21.06% | 16.49% | -15.31% | 5.01% |
| Income Before Tax | 70.59% | 24.80% | -234.58% | -31.53% | 8,996.60% |
| Income Tax Expenses | -4.74% | 71.18% | -133.32% | 20.94% | 82.28% |
| Earnings from Continuing Operations | 184.74% | -9.05% | -309.71% | -68.14% | 224.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 184.74% | -9.05% | -309.71% | -68.14% | 224.44% |
| EBIT | 37.63% | 21.06% | 16.49% | -15.31% | 5.01% |
| EBITDA | 14.31% | 10.45% | 10.14% | -11.56% | 7.45% |
| EPS Basic | 184.00% | -9.39% | -308.93% | -68.18% | 223.46% |
| Normalized Basic EPS | 66.28% | 44.04% | 62.86% | -28.70% | 15.71% |
| EPS Diluted | 183.33% | -6.67% | -350.00% | -68.18% | 220.00% |
| Normalized Diluted EPS | 66.16% | 44.01% | 64.14% | -28.84% | 14.68% |
| Average Basic Shares Outstanding | 0.36% | 0.37% | 0.58% | 0.68% | 0.70% |
| Average Diluted Shares Outstanding | 0.41% | 0.43% | -0.18% | 0.87% | 1.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |